Filter News
Area of Research
News Topics
- (-) Coronavirus (24)
- 3-D Printing/Advanced Manufacturing (17)
- Advanced Reactors (3)
- Artificial Intelligence (43)
- Big Data (26)
- Bioenergy (52)
- Biology (76)
- Biomedical (36)
- Biotechnology (14)
- Buildings (6)
- Chemical Sciences (15)
- Clean Water (13)
- Climate Change (51)
- Composites (5)
- Computer Science (107)
- Critical Materials (4)
- Cybersecurity (9)
- Decarbonization (24)
- Energy Storage (17)
- Environment (109)
- Exascale Computing (24)
- Fossil Energy (1)
- Frontier (29)
- Fusion (2)
- Grid (7)
- High-Performance Computing (52)
- Hydropower (8)
- Isotopes (2)
- Machine Learning (20)
- Materials (36)
- Materials Science (38)
- Mathematics (3)
- Mercury (7)
- Microscopy (17)
- Molten Salt (1)
- Nanotechnology (24)
- National Security (9)
- Net Zero (3)
- Neutron Science (101)
- Nuclear Energy (8)
- Partnerships (5)
- Physics (17)
- Polymers (5)
- Quantum Computing (19)
- Quantum Science (29)
- Renewable Energy (1)
- Security (6)
- Simulation (23)
- Software (1)
- Space Exploration (5)
- Summit (46)
- Sustainable Energy (36)
- Transformational Challenge Reactor (1)
- Transportation (12)
Media Contacts
To better understand the spread of SARS-CoV-2, the virus that causes COVID-19, Oak Ridge National Laboratory researchers have harnessed the power of supercomputers to accurately model the spike protein that binds the novel coronavirus to a human cell receptor.
The annual Director's Awards recognized four individuals and teams including awards for leadership in quantum simulation development and application on high-performance computing platforms, and revolutionary advancements in the area of microbial
A multi-institutional team, led by a group of investigators at Oak Ridge National Laboratory, has been studying various SARS-CoV-2 protein targets, including the virus’s main protease. The feat has earned the team a finalist nomination for the Association of Computing Machinery, or ACM, Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research.
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.
To better understand how the novel coronavirus behaves and how it can be stopped, scientists have completed a three-dimensional map that reveals the location of every atom in an enzyme molecule critical to SARS-CoV-2 reproduction.
A team led by Dan Jacobson of Oak Ridge National Laboratory used the Summit supercomputer at ORNL to analyze genes from cells in the lung fluid of nine COVID-19 patients compared with 40 control patients.
A team of researchers has performed the first room-temperature X-ray measurements on the SARS-CoV-2 main protease — the enzyme that enables the virus to reproduce.
COVID-19 has upended nearly every aspect of our daily lives and forced us all to rethink how we can continue our work in a more physically isolated world.
With the rise of the global pandemic, Omar Demerdash, a Liane B. Russell Distinguished Staff Fellow at ORNL since 2018, has become laser-focused on potential avenues to COVID-19 therapies.